|Articles|March 1, 2016
Chinese CRO Adopts Medidata CTMS
R&G provides a full range of clinical trial services for both domestic and global partners.
Advertisement
R&G Pharma Studies, a Beijing, China-based CRO, has broadened its adoption of Medidata's Clinical Cloud, becoming the first Chinese customer to use Medidata CTMS.® R&G provides a full range of clinical trial services-including regulatory affairs, clinical monitoring, data management capabilities, biostatistics, pharmacoeconomics, site management organization (SMO) services, and staffing and outsourcing-supporting studies on both a global and domestic scale.
Read the full release .
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- How Sponsors Can Modernize Tools to Support Physicians
September 9th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief Episode 7: Veeva and Merck Trial Efficiency, DCT Barriers, and Glucose Monitoring Strategies
2
Summit Therapeutics’ Bispecific Antibody Shows Positive Survival Trend in Non-Small Cell Lung Cancer
3
Pfizer, BioNTech’s Comirnaty Shows Strong Immune Response in Phase III Trial for COVID-19
4
Beyond the Algorithm: How Human-Centered AI Design Can Drive Clinical Trial Success
5